M&G PLC

Position in AMGN — Amgen Inc

CIK 1802539 London, X0

Position in AMGN

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$154,484,316

+$4,120,394 QoQ

Shares Held

439,063

-4.4% QoQ

Ownership

0.081%

of shares outstanding

% of Portfolio

0.83%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

M&G PLC holds $1,488,143,891 across 11 Drug Manufacturers - General names. AMGN ranks #3 (10.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	4,204,199	$829,152,126
2	BMY	Bristol Myers Squibb Co	5,764,140	$349,595,091
3	AMGN	Amgen Inc This page	439,063	$154,484,316
4	ABBV	AbbVie Inc.	262,231	$57,032,620
5	MRK	Merck & Co., Inc.	298,044	$35,851,712
6	JNJ	Johnson & Johnson	76,011	$18,580,128
7	PFE	Pfizer Inc	546,673	$15,350,577
8	GILD	Gilead Sciences, Inc.	95,757	$13,345,653

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$154,484,316	439,063	-4.4%	Shares	Defined	2026-05-13
2025-12-31	$150,363,922	459,393	+1.1%	Shares	Defined	2026-02-12
2025-09-30	$128,283,604	454,584	+3.8%	Shares	Defined	2025-11-07
2025-06-30	$122,276,668	437,938	+4.7%	Shares	Sole	2025-08-08
2025-03-31	$130,299,556	418,230	-5.1%	Shares	Sole	2025-05-13
2024-12-31	$114,897,931	440,830	+55.8%	Shares	Sole	2025-02-11
2024-09-30	$91,190,907	283,017	+676.5%	Shares	Sole	2024-10-31
2024-06-30	$11,388,490	36,449	+35.6%	Shares	Sole	2024-07-16
2024-03-31	$7,641,668	26,877	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.